MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
IDEXX Laboratories Operating Cycle 2011-2026 | IDXX
Annual Operating Cycle IDEXX Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128 | 135 | 136 | 127 | 106 | 106 | 115 | 110 | 119 | 120 | 142 | 132 | 120 | 126 | 127 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 142 | 106 | 123 |
Quarterly Operating Cycle IDEXX Laboratories
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129 | - | 131 | 131 | 140 | - | 141 | 139 | 140 | - | 144 | 141 | 140 | - | 69.4 | 61 | 119 | - | 110 | 105 | 107 | - | 106 | 122 | 113 | 40.6 | 109 | 107 | 110 | 41.3 | 108 | 103 | 107 | 42.3 | 112 | 111 | 116 | 42.1 | 113 | 110 | 126 | 43 | 137 | 137 | 136 | 39.5 | 122 | 121 | 124 | 40.7 | 122 | 120 | 125 | 39.5 | 129 | 123 | 124 | 42 | 128 | 125 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 144 | 39.5 | 107 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Co-Diagnostics
CODX
|
1.79 K | $ 1.27 | -22.09 % | $ 1.69 M |  USA |
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 15.81 | -2.35 % | $ 478 M | USA |
 |
Agilent Technologies
A
|
161 | $ 111.6 | -1.45 % | $ 33.9 B | USA |
 |
Castle Biosciences
CSTL
|
97.4 | $ 19.18 | 1.59 % | $ 556 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
198 | $ 141.04 | -1.54 % | $ 22.4 B | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
121 | $ 93.57 | -3.21 % | $ 6.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 417.23 | -0.46 % | $ 12 B | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 037.75 | -0.4 % | $ 21.4 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M |  China |
 |
Myriad Genetics
MYGN
|
95.1 | $ 3.62 | -0.14 % | $ 335 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
102 | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 153.0 | -3.85 % | $ 7.58 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 18.63 | -1.61 % | $ 417 M | USA |
 |
Natera
NTRA
|
81.5 | $ 188.85 | -4.1 % | $ 18.6 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 25.25 | -0.98 % | $ 23.9 B |  Niderland |
 |
Guardant Health
GH
|
128 | $ 94.7 | -4.02 % | $ 11.9 B | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 5.72 | -1.8 % | $ 239 M | USA |
 |
Personalis
PSNL
|
63.8 | $ 6.46 | -3.73 % | $ 576 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.04 K | $ 53.0 | 0.02 % | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 117.71 | 0.53 % | $ 9.71 B |  Irlanda |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
204 | $ 2.36 | -2.12 % | $ 5.42 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 252.45 | -0.62 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 438.41 | -2.17 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.56 | -3.63 % | $ 201 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 48.53 | -8.35 % | $ 2.9 B | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 8.22 | -2.55 % | $ 1.78 B | USA |
 |
Waters Corporation
WAT
|
834 | $ 330.33 | -0.86 % | $ 19.7 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 186.95 | -0.53 % | $ 20.8 B | USA |